The CEO of GH Research, Dr. Velichka Valcheva, pointed out that the response addressed the FDA’s requests with comprehensive ...

BSA Behavioral Health announced it is expanding its mental health services to include Spravato (esketamine) nasal spray, for ...

Research on synthetic psychedelics progresses, and there's hope to prove psilocybin safe and effective in intractable ...

Busting stigma is no small task, especially when it involves convincing the public that a psychedelic drug might one day be ...

A phase 2 trial shows that a single dose of psilocybin provides lasting relief from symptoms of depression and anxiety. New ...

Earlier identification is also of interest due to the possibility that earlier intervention may be more effective with more ...

Deep transcranial magnetic stimulation was safe and effective in treating adolescents and young adults with major depressive ...

Roughly one in ten Americans suffers from major depressive disorder (MDD) at any given time. In total, up to 20 percent of ...

Introduction Major depressive disorder (MDD) is a major global healthcare challenge. This is, in part, due to the lack of treatment response and chronic course of MDD. Such a course of illness is ...

Medical University of South Carolina (MUSC) is working to make treatment for depression more accessible with its new mobile ...

In a 28-day treatment regimen, ART12.11 significantly reversed behavioral impairments in male rats exposed to chronic stress. The compound improved sucrose preference and social motivation, ...